The ADHD medication titration process is frustrating, exhausting, and psychologically draining, causing unpleasant side effects and lack of therapeutic benefits. Executive dysfunction, memory issues, and people-pleasing tendencies prevent patients from effectively communicating their experiences to psychiatrists during brief check-ins.
The ADHD medication titration process is frustrating, exhausting, and psychologically draining, causing unpleasant side effects, lack of therapeutic benefits, and administrative burdens like monthly pharmacy visits, while symptoms like memory issues and people-pleasing prevent the user from communicating effectively with their psychiatrist.
Titration is kicking my ass
Adults with ADHD managing complex dose adjustments who struggle with memory issues, people-pleasing, and communication barriers during psychiatric check-ins.
Repeated struggles with adverse side effects across multiple medications combined with communication barriers during psychiatric visits.
Purpose-built for the psychological and executive-function barriers of ADHD titration, focusing specifically on bridging the patient-psychiatrist communication gap rather than general health logging.
A mobile-first structured daily symptom and side-effect tracker designed specifically for ADHD titration, featuring automated weekly summaries and conversation preparation prompts that help patients advocate for themselves during psychiatric appointments.
Patients spending hundreds of dollars on ineffective medications and appointments will readily pay a nominal monthly fee to optimize a grueling, multi-month titration process that directly impacts their daily productivity and mental health.
“Turn daily symptom tracking into an effortless conversation guide for your psychiatrist.”
A mobile-first structured daily symptom and side-effect tracker designed specifically for ADHD titration, featuring automated weekly summaries and conversation preparation prompts that help patients advocate for themselves during psychiatric appointments.
Target online ADHD communities and support spaces (r/ADHD, specialized Discord servers, and student support groups)
Users may abandon the app once they find a stable medication dose, shortening lifetime value.
Users struggling with ADHD may find daily logging tedious and stop engaging during high-fatigue periods.
Risk of users treating app outputs as medical advice rather than a communication aid for their doctor.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
It sits at the intersection of "adhd", "b2c", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
